Rahul Aras
Biotech executive and scientist serving as President and CEO of Iterion Therapeutics, with prior experience founding and leading venture-backed biotech companies focused on gene and regenerative therapies and advancing oncology programs targeting the Wnt/β-catenin pathway.
Best podcasts with Rahul Aras
Ranked by the Snipd community
Mar 9, 2026 • 49min
Developing Novel Cancer Drugs On A Budget With Iterion Therapeutics' Rahul Aras, Ph.D.
Rahul Aras, Ph.D., biotech executive and CEO of Iterion Therapeutics, previously founded ventures in gene and regenerative therapies. He discusses advancing a novel Wnt/β-catenin-targeting cancer drug on a lean budget. Conversations cover clinical progress in HCC and desmoid tumors, capital-efficient trial design under $50M, combination strategies, and operating a biotech from Houston.
